Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema
감성철, 최세민, Yoon Sol, Choi Jae-Hui, 이성현, 화정석, 정기현, 현재석,
소속 상세정보
감성철 ( Kam Sung-Chul )
Gyeongsang National University School of Medicine Department of Urology
최세민 ( Choi See-Min )
Gyeongsang National University School of Medicine Department of Urology
( Yoon Sol )
Gyeongsang National University School of Medicine Department of Urology
( Choi Jae-Hui )
Gyeongsang National University School of Medicine Department of Urology
이성현 ( Lee Seong-Hyun )
Gyeongsang National University School of Medicine Department of Urology
화정석 ( Hwa Jeong-Seok )
Gyeongsang National University School of Medicine Department of Urology
정기현 ( Chung Ky-Hyun )
Gyeongsang National University School of Medicine Department of Urology
현재석 ( Hyun Jae-Seog )
Gyeongsang National University School of Medicine Department of Urology
KMID : 0358320140550110732
Abstract
Purpose: Transrectal ultrasound (TRUS)-guided biopsy of the prostate is usually safe. However, some patients are hospitalized owing to complications from TRUS biopsy. We identified the risk factors for complications and effective preventive measures for treating complications after TRUS biopsy.
Materials and Methods: Medical records and radiological images of 1,083 patients who underwent TRUS biopsy of the prostate over 10 years in Gyeongsang National University Hospital were examined retrospectively to investigate the correlation between complications after TRUS biopsy and preventive antibiotics, prebiopsy enema, number of biopsy cores, and pathological findings.
Results: Complications occurred in 69 patients (6.4%). The complication rates of the 1,008 patients who received antibiotics and the 75 patients who did not were 6.3% and 8.0%, respectively (p=0.469). Complication rates of the pre-biopsy enema group (n=658) and the group without prebiopsy enema (n=425) were 4.7% and 8.9%, respectively (p=0.007). Complication rates of the 6-core biopsy group (n=41) and the 12-core biopsy group (n=955) were 7.3% and 6.3%, respectively (p=0.891). Complication rates of the prostate cancer group (n=306) and the no prostate cancer group (n=713) were 6.2% and 6.6%, respectively (p=0.740).
Conclusions: A prebiopsy enema was associated with a reduced risk of complications after TRUS biopsy. Preventive antibiotics, number of biopsy cores, and pathological findings did not significantly influence the complication rate.
키워드
Biopsy; Complications; Enema; Prostate
원문 및 링크아웃 정보
등재저널 정보